Sun Pharma acquires rights for Oxra, Oxramet and Oxraduo from AstraZeneca
Consequently, AstraZeneca India and Sun Pharma have now discontinued the Distribution Agreement signed in 2016 and have entered into a Transition Supply Agreement with effect from 28th May 2021